US tech titans Elon Musk, Mark Zuckerberg and Jeff Bezos are taking a prominent place in the new Trump era, but another player from another era -- Oracle boss Larry Ellison -- is making a surprise return.

A potential deal to restructure TikTok’s ownership could reshape its global operations, minimising Chinese influence while preserving its U.S. presence.

Elon Musk, real estate magnate Frank McCourt, and Shark Tank’s Kevin O’Leary are also interested in taking over TikTok, according to reports.

Yes, that's the name of a 1994 Roland Emmerich movie. It's now a big infrastructure project to help power tech giants' foray into AI.

What is Larry Ellison's net worth in 2025? What are the secrets behind the 80-year-old from New York City, who is currently considered the second-wealthiest man in the world behind

As Oracle (ORCL) joins the Stargate Project, a new $500B AI infrastructure initiative, are there risks to Microsoft (MSFT) - OpenAI partnership. Read more here.

During the first Trump TikTok ban effort, Oracle and Walmart were set to take a 20 percent stake in 'TikTok Global,' which included US operations as well as undisclosed other nations. Larry Ellison, Oracle founder, was a major supporter of Trump's 2016 bid.

Microsoft won’t be the sole cloud provider for OpenAI but can decide whether to deliver the capacity or allow another company to do it.

Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.

Earlier, Trump had expressed openness to Tesla CEO Elon Musk or Oracle Chairman Larry Ellison acquiring the Chinese social media platform

Zero, a model trained via large-scale reinforcement learning (RL) without supervised fine-tuning (SFT) as a preliminary step, demonstrates remarkable reasoning capabilities. Through RL, DeepSeek-R1-Zero naturally emerges with numerous powerful and intriguing reasoning behaviors.

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early through a simple blood test, followed by gene sequencing of the tumour